Fibroblast growth factor downregulates expression of a basic helix- loop-helix-type transcription factor, scleraxis, in a chondrocyte-like cell line, TC6

Journal of Cellular Biochemistry

Volumn 70, Issue 4, 1998, Pages 468-477

  Kawa uchi, Toshiyuki ^a   Nifuji, Akira ^a   Mataga, Nobuko ^a   Olson, Eric N ^b   Bonaventure, Jacky ^c   Shinomiya, Ken Ichi ^a   Liu, Ying ^a   Noda, Masaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

BHLH; Chondrocyte; FGF; Scleraxis; Transcription factor

Indexed keywords

FIBROBLAST GROWTH FACTOR; HELIX LOOP HELIX PROTEIN; SCLERAXIS; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SCLEROTOME; TRANSCRIPTION REGULATION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE; CHONDROCYTES; DOWN-REGULATION; FIBROBLAST GROWTH FACTORS; HELIX-LOOP-HELIX MOTIFS; HUMANS; RECEPTORS, FIBROBLAST GROWTH FACTOR; RNA, MESSENGER; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0032531270     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980915)70:4<468::AID-JCB4>3.0.CO;2-H     Document Type: Article

References (41)

1. Amaya E, Musci TJ, Kirschner MW (1991): Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell 66:257-270.
2. Baird A, Bohlen P (1991): Fibroblast growth factors. In Sporn MB, Roberts AB (eds.): "Peptide Growth Factors and Their Receptors." New York: Springer-Verlag, pp 369-418.
3. Bonaventure J, Rousseau F, Legeai-Mallet L, Le Merrer M, Munnich A, Maroteaux P (1996): Common mutation in the fibroblast growth factor reception 3 (FGFR3) gene account for achondroplasia, lypochondroplasia, and thanatophoric dwarfism. Am J Med Gen 63:148-154.
4. Burris LW, Zuber ME, Lueddecke BA, Olwin BB (1992): Identification ofa cystein-rich receptor for fibroblast growth factors. Mol Cell Biol 12:5600-5609.
5. Chomczynski P, Sacchi N (1987): Single-step isolation by acide guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Cserjesi P, Brown D, Ligon K, Lyons G, Copeland N, Gilbert D, Jenkin N, Olson E (1995): Scleraxis: Abasic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development 181: 1099-1110.
7. Cuevas P, Burgos J, Baird A (1988): Basic fibroblast growth factors (FGF) promotes cartilage repair in vivor. Biochem Biophys Res Commun 156:611-618.
8. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P (1996): Fibroblast growth factor reception 3 is a negative regulator of bone growth. Cell 84:911-921.
9. Feinberg AP, Vogelstein B (1983): A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. anal Biochem 132:6-13.
10. Frenz DA, Liu W, Williams JD, Hatcher V, Galinovic-Shwartz V, Flanders KC, Van De Water TR (1994): Induction of chondrogenesis, requirement for synergistic interaction of basic fibroblast growth factor and transofrming growth factor-beta.Development 120:415-424.
11. Gospodarowicz D (1990): Fibroblast growth factor: Chemical structure and biologic function. Clin Orthop 257:231-248.
12. Jan YN, Jan LY (1993): HLH protein, fly neurogenesis, and vertebrate myogenesis. Cell 75: 827-830.
13. Jingushi S, Heydemann A, Macay LR, Bolander ME (1990): Acidic fibroblast growth factor (a FGF) injection stimulates cartilage enlargement andinhibits cartilage gene expression in rat fracture healing. J Orthop Res 8:364-371.
14. Jingushi S, Scully SP, Joyce ME, Sugioka Y, Bolander ME (1995): Transforming growth factor B1 and fibroblast growth factors in rat growth plate. J Orthop Res 13:761-768.
15. Kadesch T (1993): Consequences of heteromeric interactions among helix-loop-helix proteins. Cell Growth & Diff 4:49-55.
16. Kiefer P, Peters G, Dickson C (1993): Retention of fibroblast growth factor 3 in the Golfi complex may regulate its export from cells. Mol Cell Biol 13:5781-5793.
17. Lee JE, Hollenberg SM, Sneider L, Turner DL, Lipnick N, Weintraub H (1995): Conversion of Xenopus ectoderm into neurons by Neuro D, a basic helix-loop-helix protein. Science 268: 836-844.
18. Lie Y, Watanabe H, Yamada Y, Olson E, Nifuji A, Noda M (1997): Overexpression of a single helix-loop-helix type transcription factor, scleraxis, enchances aggrecan gene expression in osteoblastic osteosarcoma ROS17/2.8 cells. J Biol Chem 272:29880-29885.
19. Liu Y, Nifuji A, Olson E, Noda M (1996): Sclerotome-related helix loop Helix type transcription factor (scleraxis) mRNA is expressed in osteoblasts and its level is enhanced by type-beta transforming growth factor. J Endocrinology 151:491-499.
20. Liu Y, Wozney J, Nifuji A, Olson E, Noda M (1997): Scleraxis is expressed in C2C12 myoblasts and its level is down-regulated by bone morphogenetic protein-2 (BMP2). J Cell Biochem 67:1-9.
21. Liu Y, Watanabe H, Yamada Y, Olson E, Nifuji A, Noda M (1997): Overexpression of a single helix-loop-helix type transcription factor, scleraxis, enhances aggrecan gene expression in osteoblastic osteosarcoma ROS17/2.8 cells. J Biol Chem 272(47):29880-29885.
22. Ma Q, Kintner C, Anderson DJ (1996): Identification of neurogenin, a vertebrate neuronal determination gene. Cell 87: 43-52.
23. Mason IJ (1994): The ins and outs of fibroblast growth factors. Cell 78:547-552.
24. Mataga N, Tamura M, Yanai N, Shinomura T, Kimata K, Obinata M, Noda M (1996): Establishment of a novel chondrocyte-like cell line derived from transgenic mice harboring the temperature-sensitive simian virus 40 large T-antigen gene. J Bone Miner Res 11:1646-1654.
25. McEwen DG, Ornitz DM (1967): Determinaton of fibroblast growth factor reception expression in mouse, rat and human samples using a single primer pair. Biotechniques 22:1068-1070.
26. Muenke M, Schell U, Hehr A, Robin N, Loskin HW, Schinzel A, Pulleyn L, Rutland P, Readon W, Malcolm S, Winter R (1994): A common mutation in the fibroblast growth factor reception 1 gene in Pfeiffer syndrome. Nature Genet 8:269-274.
27. Noda M, Yoon K, Rodan GA, Koppel, DE (1987): High lateral mobility of endogenous and transfected alkaline phosphatase: A phosphatidylinositol anchored membrane protein. J Cell Biol 105:1671-1677.
28. Noda M (1989): Transcriptional regulation of osteocalcin production by type beta transforming growth factor in rat osteoblast-like cells. Endocrinology 124:612-617.
29. Noda, M and Vogel, R. Transcriptional regulation of type beta 1 transforming growth factor gene expression by fibroblast growth factor. Journal of Cell Biology 109:2529-2535, 1989.
30. Olson EN, Klein WH (1994): bHLH factors in muscle development; deadlines and commitments, what to leave in and what to leave out. Genes Development 8: 1-8.
31. Ornitz DM, XU J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M (1996): Receptor specificity of the fibroblast growth factor family. J Biol Chem 271: 15292-15297.
32. Peters KG, Werner S, Chen G, William LT (1992): Two FGF receptor genes are differentially expressed in epitherial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114:233-243.
33. Peters K, Ornitz D, Werner S, Williams L (1993): Unique expression pattern of the FGF reception 3 gene during mouse organogensis.Dev Biol 155:423-430.
34. Rapraeger AC, Krufka A, Olwin Bb (1991): Requirement of heparan sulphate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705-1708.
35. Reardon W, Winter R, Rutlund P, Pulleyn L, Jones B, Malcolm S (1994): Mutations in the fibroblast growth factor receptor 2 gene cause Crouson syndrom. Nature Genet 8:98-103.
36. Rousseou F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A (1994): Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371:252-254.
37. Shiang R, Thompson LM, Zhy YZ, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ (1994): Mutations in the transmenbrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342.
38. Tavormina PL, Shian R, Thompson LM, ZhuY-Z, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ (1995): Thanatophoric dysplasia (type I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet 9:321-328.
39. Twal WO, Vasilatos-Younken R, Gay CV, Leach RM Jr (1994): Isolation and localization of basic fibroblast growth factor-immunoreactive substance in the epiphisial growth plate. J Bone Miner Res 9:1737-1744.
40. Wroblewski J, Edwall-Arvidsson C (1995): Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiation. J Bone Miner Res 10:735-742.
41. Yayon A, Klagsburn M, Esko JD, Leder P, Ornitz DM (1991): Cell surface, heparin-like molecules are required for binding are required for binging of basic fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Cell 64:841-848.